Product information

Bortezomib Eugia 3.5 mg
3.5 mg
bortezomib
4332326
0 / 10
Locked

Product properties

179324-69-7
L01XG01
Eugia Pharma (Malta)
Powder for solution for injection
€361.29
BE574293
05401026001296
M44
Public
574293-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Other reason) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Other reason

Alternative available

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
3.664 mg
Excipient
35 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
364 days
1
0
02/07/2025